Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Hair loss occurs due to fewer papillary cells, smaller follicles, and shorter growth phases.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Future acne treatments should aggressively target inflammation to prevent scarring.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Acne is a chronic disease linked to various systemic conditions and has significant psychological and social effects.

Nuclear hormone receptors play a significant role in skin wound healing and could lead to better treatment methods.

No cure for female pattern hair loss, but various effective treatments exist.

Hirsutism can occur in women with PCOS even if their androgen levels are normal, making diagnosis challenging.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Multiple treatments work best for hair loss.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Plant-based drugs are effective and safe alternatives for managing PCOS symptoms.

Certain diets can affect skin conditions, but more research is needed to understand these relationships fully.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Androgen self-administration might be controlled by membrane receptors, not nuclear ones.

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Hormonal treatments can improve acne, but they come with potential side effects and risks.